Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,664 | 863 | 97.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $220.00 | 2 | 1.7% |
| Education | $143.10 | 7 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,269 | 237 | $0 (2024) |
| Janssen Biotech, Inc. | $1,466 | 98 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,189 | 95 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $977.47 | 66 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $608.00 | 36 | $0 (2024) |
| Braintree Laboratories, Inc. | $527.57 | 37 | $0 (2024) |
| PFIZER INC. | $499.65 | 32 | $0 (2024) |
| Allergan, Inc. | $474.65 | 40 | $0 (2020) |
| Celgene Corporation | $309.02 | 23 | $0 (2024) |
| UCB, Inc. | $308.42 | 21 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,844 | 165 | ABBVIE INC. ($711.83) |
| 2023 | $2,431 | 157 | ABBVIE INC. ($637.77) |
| 2022 | $1,848 | 133 | ABBVIE INC. ($484.53) |
| 2021 | $721.02 | 59 | AbbVie Inc. ($216.99) |
| 2020 | $489.26 | 27 | Janssen Scientific Affairs, LLC ($119.70) |
| 2019 | $1,410 | 121 | AbbVie, Inc. ($285.97) |
| 2018 | $1,360 | 103 | AbbVie, Inc. ($360.13) |
| 2017 | $1,923 | 107 | AbbVie, Inc. ($498.49) |
All Payment Transactions
872 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: GI | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Rare Disease | ||||||
| 12/06/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: GI COLON PREP | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Boston Scientific Corporation | CRE PRO (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: CRE_ENDO | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: GI COLON PREP | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: GI | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.79 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 753 | 866 | $743,900 | $98,068 |
| 2022 | 11 | 705 | 823 | $624,210 | $87,234 |
| 2021 | 9 | 696 | 877 | $415,672 | $93,312 |
| 2020 | 11 | 572 | 727 | $311,171 | $65,921 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 306 | $106,794 | $31,637 | 29.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 152 | 153 | $277,695 | $21,270 | 7.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 106 | 106 | $169,070 | $11,742 | 6.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 45 | 45 | $85,388 | $10,206 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 96 | $22,560 | $6,548 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $22,880 | $6,137 | 26.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $33,880 | $3,921 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $14,432 | $3,041 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 30 | $6,900 | $2,077 | 30.1% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 17 | 17 | $4,301 | $1,489 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 294 | $97,832 | $27,899 | 28.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 117 | 117 | $206,495 | $15,812 | 7.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 89 | 94 | $146,215 | $10,060 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 118 | $27,730 | $9,078 | 32.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 30 | $55,328 | $6,330 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $20,400 | $5,215 | 25.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 25 | 25 | $39,734 | $4,825 | 12.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $9,826 | $2,441 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $10,208 | $2,368 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 35 | $7,662 | $2,070 | 27.0% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 11 | 11 | $2,780 | $1,135 | 40.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 257 | 396 | $77,220 | $39,865 | 51.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 109 | 109 | $140,848 | $16,502 | 11.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 82 | 82 | $24,600 | $10,205 | 41.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 95 | 97 | $91,244 | $9,390 | 10.3% |
About Dr. Glenn Osias, MD
Dr. Glenn Osias, MD is a Gastroenterology healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164422788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Osias, MD has received a total of $13,027 in payments from pharmaceutical and medical device companies, with $2,844 received in 2024. These payments were reported across 872 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($12,664).
As a Medicare-enrolled provider, Osias has provided services to 2,726 Medicare beneficiaries, totaling 3,293 services with total Medicare billing of $344,535. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Princeton, NJ
- Active Since 07/26/2005
- Last Updated 12/11/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1164422788
Products in Payments
- STELARA (Biological) $1,389
- XIFAXAN (Drug) $935.54
- RINVOQ (Biological) $849.24
- Humira (Biological) $800.24
- LINZESS (Drug) $505.03
- ENTYVIO (Biological) $498.87
- Linzess (Drug) $490.89
- XELJANZ (Drug) $465.86
- SKYRIZI (Biological) $397.97
- HUMIRA (Biological) $354.89
- Entyvio (Biological) $333.09
- ZEPOSIA (Drug) $309.02
- Cimzia (Drug) $308.42
- VIBERZI (Drug) $294.29
- IBSRELA (Drug) $250.36
- VOQUEZNA (Drug) $226.49
- OCALIVA (Drug) $222.37
- SUTAB (Drug) $220.50
- ZENPEP (Drug) $188.79
- SUCRAID (Drug) $182.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Princeton
Dr. Anish Sheth, Md, MD
Gastroenterology — Payments: $205,196
Amy Shriver, M.d, M.D
Gastroenterology — Payments: $86,913
Aaron Bellows, M.d, M.D
Gastroenterology — Payments: $7,850
Robert Meirowitz, Md, MD
Gastroenterology — Payments: $7,725
Aloysius Rho, Md, MD
Gastroenterology — Payments: $7,329
Dr. Darren Andrade, M.d, M.D
Gastroenterology — Payments: $5,859